The German Heart Center Berlin (DHZB) Foundation and Noah Labs have entered a strategic collaboration and investment agreement to develop breakthrough voice-based biomarkers for heart failure. The collaboration is in the field of diagnostics and monitoring of cardiovascular diseases. It includes joint clinical research and development, as well as an investment in the company.

Noah Labs is pleased to announce that we have achieved ISO 13485 certification as a medical device manufacturer. This is a testament to our commitment to quality and excellence in all of our product offerings.

With the signing of the joint declaration, Noah Labs was accepted as the very first startup among globally leading pharma and medtech firms to join Herz-Hirn-Allianz.

Noah Labs has recently been selected and today formally joined the Berlin Startup Stipends (BSS) Health track.

Noah Labs today officially joined EIT Health's flagship program Startups meet Healthcare Providers.

Noah Labs receives significant funding from the European Regional Development Fund (ERDF) and the state of Brandenburg for the ‘Noah Labs Pre-Sense’ project. This funding supports the development of an innovative application for the early detection of cardiac decompensation by analysing multiparametric vital data, with the aim of improving diagnostics and healthcare and driving innovation in the field of digital healthcare solutions.